Determining Dose & Schedule for Small Molecules & Antibody Drug Conjugates in Phase I Oncology Clinical Trials
Time: 4:45 pm
day: Conference Day One PM
Details:
- Optimal biological and effective dose finding guidance for clinical development
- Preclinical modelling for human dose prediction for solid tumors
- Opportunity in hematological malignancies to measure receptor occupancy for dose selection
